Product logins

Find logins to all Clarivate products below.


Clot Management Devices | Market Insights | Asia Pacific| 2017

The Asia Pacific market for clot management devices is characterized by a combination of rapidly expanding and relatively mature market segments. The dynamics of the market differs by country, with device adoption hinging largely on positive clinical data and favorable reimbursement in countries such as Australia and South Korea, while device pricing remains a key factor in China and India.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…